Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine

被引:43
作者
de Kleijn, E
van Eijndhoven, L
Vermont, C
Kuipers, B
van Dijken, H
Rümke, H
de Groot, R
van Alphen, L
van den Dobbelsteen, G
机构
[1] Natl Inst Publ Hlth & Environm, RIVM, Lab Vaccine Res, NL-3720 BA Bilthoven, Netherlands
[2] Univ Rotterdam, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands
关键词
isotype distribution; meningococcal B vaccine; children;
D O I
10.1016/S0264-410X(01)00371-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A clinical phase II trial with the RIVM hexavalent OMV vaccine containing six different PorAs was carried out in toddlers (2-3 years) and schoolchildren (7-8 years) in The Netherlands. Children were vaccinated three times (0, 2, 8 months). Sera after two and three vaccinations were analysed for serum bactericidal activity (SBA) and isotype distribution in whole cell enzyme linked immunosorbent assay (ELISA). The SBA after vaccination against the six PorAs was significantly different. We investigated whether the age specific and PorA specific differences in SBA titers correlated with differences in PorA specific IgG isotype distribution. The SBA titers were higher in toddlers compared with schoolchildren. After vaccination, IgG I antibodies dominated the response followed by IgG3 antibodies. IgG2 levels were low. whereas IgG4 was not detected. Irrespective of PorA, IgG total and isotype specific titers after two and three vaccinations were significantly higher in toddlers than in schoolchildren. A weak correlation was found between IgG total or IgG I and SBA. Although the immunogenicity of the six PorAs is very different, the isotype distribution was similar for all six tested PorAs. We conclude that the RIVM hexavalent PorA vesicle vaccine induces bactericidal antibodies mainly of the IgG1 and IgG3 isotypes that are considered to be most important for protection against disease. The isotype distribution of the response is not age-dependent. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:352 / 358
页数:7
相关论文
共 29 条
  • [1] COMPARISON AMONG OPSONIC ACTIVITY, ANTIMENINGOCOCCAL IMMUNOGLOBULIN-G RESPONSE, AND SERUM BACTERICIDAL ACTIVITY AGAINST MENINGOCOCCI IN SERA FROM VACCINEES AFTER IMMUNIZATION WITH A SEROGROUP-B OUTER-MEMBRANE VESICLE VACCINE
    AASE, A
    BJUNE, G
    HOIBY, EA
    ROSENQVIST, E
    PEDERSEN, AK
    MICHAELSEN, TE
    [J]. INFECTION AND IMMUNITY, 1995, 63 (09) : 3531 - 3536
  • [2] EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY
    BJUNE, G
    HOIBY, EA
    GRONNESBY, JK
    ARNESEN, O
    HOLSTFREDRIKSEN, J
    HALSTENSEN, A
    HOLTEN, E
    LINDBAK, AK
    NOKLEBY, H
    ROSENQVIST, E
    SOLBERG, LK
    CLOSS, O
    ENG, J
    FROHOLM, LO
    LYSTAD, A
    BAKKETEIG, LS
    HAREIDE, B
    [J]. LANCET, 1991, 338 (8775) : 1093 - 1096
  • [3] Borrow R, 2000, FEMS IMMUNOL MED MIC, V28, P79, DOI 10.1111/j.1574-695X.2000.tb01460.x
  • [4] EFFICACY, SAFETY, AND IMMUNOGENICITY OF A MENINGOCOCCAL GROUP-B (15-P1.3) OUTER-MEMBRANE PROTEIN VACCINE IN IQUIQUE, CHILE
    BOSLEGO, J
    GARCIA, J
    CRUZ, C
    ZOLLINGER, W
    BRANDT, B
    RUIZ, S
    MARTINEZ, M
    ARTHUR, J
    UNDERWOOD, P
    SILVA, W
    MORAN, E
    HANKINS, W
    GILLY, J
    MAYS, J
    [J]. VACCINE, 1995, 13 (09) : 821 - 829
  • [5] BURTON DR, 1986, MONOGR ALLERGY, V19, P7
  • [6] Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins
    Cartwright, K
    Morris, R
    Rümke, H
    Fox, A
    Borrow, R
    Begg, N
    Richmond, P
    Poolman, J
    [J]. VACCINE, 1999, 17 (20-21) : 2612 - 2619
  • [7] Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
    Claassen, I
    Meylis, J
    vanderLey, P
    Peeters, C
    Brons, H
    Robert, J
    Borsboom, D
    vanderArk, A
    vanStraaten, I
    Roholl, P
    Kuipers, B
    Poolman, J
    [J]. VACCINE, 1996, 14 (10) : 1001 - 1008
  • [8] Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age
    de Kleijn, ED
    de Groot, R
    Labadie, J
    Lafeber, AB
    van den Dobbelsteen, G
    van Alphen, L
    van Dijken, H
    Kuipers, B
    van Omme, GW
    Wala, M
    Juttmann, R
    Rümke, HC
    [J]. VACCINE, 2000, 18 (15) : 1456 - 1466
  • [9] DEMORAES JC, 1992, LANCET, V340, P1074
  • [10] LABORATORY CORRELATES OF PROTECTION AGAINST HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE - IMPORTANCE OF ASSESSMENT OF ANTIBODY AVIDITY AND IMMUNOLOGICAL MEMORY
    GRANOFF, DM
    LUCAS, AH
    [J]. COMBINED VACCINES AND SIMULTANEOUS ADMINISTRATION: CURRENT ISSUES AND PERSPECTIVES, 1995, 754 : 278 - 288